-
Innovation Ranking
NewInnovation Ranking – NGK Spark Plug Co Ltd
Niterra Co Ltd (Niterra), formerly NGK Spark Plug Co Ltd manufactures and sells spark plugs and related products for internal-combustion engines; medical equipment; and technical ceramics and applicable products. The company’s major products include spark plugs, glow plugs, sensors and plugs, semiconductor packages and substrates, cutting tools, medical products and fine ceramics. Its spark plugs are used in various applications, including two-wheel and four-wheel vehicles, airplanes, rockets, co-generation system, emergency power and pomp drive, among others. The company also sells...
-
Product Insights
NewOrthodontic Materials and Products Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Orthodontic Materials and Products Pipeline Market Report Overview Orthodontic materials and products are designed to correct teeth and jaws that are positioned improperly. The orthodontic materials and products pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pirtobrutinib in Diffuse Large B-Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pirtobrutinib in Diffuse Large B-Cell Lymphoma Drug Details: Pirtobrutinib (Jaypirca) is an anti-neoplastic agent. It is...
-
Product Insights
Non Alcoholic Fatty Liver Disease (NAFLD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Non Alcoholic Fatty Liver Disease (NAFLD) - Drugs In Development, 2023’, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Interstitial Lung Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Interstitial Lung Fibrosis - Drugs In Development, 2023’, provides an overview of the Interstitial Lung Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Heart Valve Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Heart Valve Disease - Drugs In Development, 2023’, provides an overview of the Heart Valve Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Heart Valve Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Aortic Valve Diseases – Drugs In Development, 2023
Global Markets Direct’s, ‘Aortic Valve Diseases - Drugs In Development, 2023’, provides an overview of the Aortic Valve Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aortic Valve Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Aortic Valve Stenosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Aortic Valve Stenosis - Drugs In Development, 2023’, provides an overview of the Aortic Valve Stenosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aortic Valve Stenosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Huntington Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Huntington Disease - Drugs In Development, 2023’, provides an overview of the Huntington Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Huntington Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Hemophilia A (Factor VIII Deficiency) – Drugs In Development, 2023
Global Markets Direct’s, ‘Hemophilia A (Factor VIII Deficiency) - Drugs In Development, 2023’, provides an overview of the Hemophilia A (Factor VIII Deficiency) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hemophilia A (Factor VIII Deficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...